lupus/vitiligo therapy (Rheos Medicines)

N/A

Report date: 2025/01/26 17:13:17
NME

Base Information

Drug Namelupus/vitiligo therapy (Rheos Medicines)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT lymphocytes inhibitors
TargetsUpdating
Therapy Area/IndicationsVitiligoLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRheos Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesRheos Medicines Inc
Inactive CompaniesN/A
Active IndicationsVitiligoLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A